Christopher W Anderson
Overview
Explore the profile of Christopher W Anderson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park J, Riaz M, Qin L, Zhang W, Batty L, Fooladi S, et al.
Cell Stem Cell
. 2024 Dec;
32(1):137-143.e6.
PMID: 39644899
Tissue-engineered vascular conduits (TEVCs), often made by seeding autologous bone marrow cells onto biodegradable polymeric scaffolds, hold promise toward treating single-ventricle congenital heart defects (SVCHDs). However, the clinical adoption of...
2.
Ellis M, Riaz M, Huang Y, Anderson C, Hoareau M, Li X, et al.
Arterioscler Thromb Vasc Biol
. 2024 May;
44(7):1674-1682.
PMID: 38752350
Background: A series of incurable cardiovascular disorders arise due to improper formation of elastin during development. Supravalvular aortic stenosis (SVAS), resulting from a haploinsufficiency of , is caused by improper...
3.
Luo J, Qin L, Park J, Kural M, Huang Y, Shi X, et al.
Circ Res
. 2022 Feb;
130(6):925-927.
PMID: 35189711
No abstract available.
4.
Ellis M, Riaz M, Huang Y, Anderson C, Luo J, Park J, et al.
J Mol Cell Cardiol
. 2022 Jan;
163:167-174.
PMID: 34979103
Tissue engineered vascular grafts possess several advantages over synthetic or autologous grafts, including increased availability and reduced rates of infection and thrombosis. Engineered grafts constructed from human induced pluripotent stem...
5.
Luo J, Shi X, Lin Y, Yuan Y, Kural M, Wang J, et al.
Acta Biomater
. 2020 Nov;
119:184-196.
PMID: 33166710
Tissue engineered vascular grafts (TEVGs) represent a promising therapeutic option for emergency vascular intervention. Although the application of small-diameter TEVGs using patient-specific primary endothelial cells (ECs) to prevent thrombosis and...
6.
Luo J, Lin Y, Shi X, Li G, Kural M, Anderson C, et al.
Acta Biomater
. 2020 Nov;
119:155-168.
PMID: 33130306
Development of mechanically advanced tissue-engineered vascular grafts (TEVGs) from human induced pluripotent stem cell (hiPSC)-derived vascular smooth muscle cells (hiPSC-VSMCs) offers an innovative approach to replace or bypass diseased blood...
7.
Park J, Anderson C, Sewanan L, Kural M, Huang Y, Luo J, et al.
Acta Biomater
. 2019 Oct;
102:220-230.
PMID: 31634626
Single ventricle heart defects (SVDs) are congenital disorders that result in a variety of complications, including increased ventricular mechanical strain and mixing of oxygenated and deoxygenated blood, leading to heart...
8.
Wolf M, Ganguly S, Wang T, Anderson C, Sadtler K, Narain R, et al.
Sci Transl Med
. 2019 Feb;
11(477).
PMID: 30700576
Biomaterials in regenerative medicine are designed to mimic and modulate tissue environments to promote repair. Biologic scaffolds (derived from decellularized tissue extracellular matrix) promote a wound-healing (proregenerative) immune phenotype and...
9.
Anderson C, Boardman N, Luo J, Park J, Qyang Y
Curr Cardiol Rep
. 2017 Mar;
19(4):34.
PMID: 28324469
Purpose Of Review: The purpose of this review is to provide a broad overview of current trends in stem cell research and its applications in cardiovascular medicine. Researches on different...
10.
Anderson C, Zhang Y
J Health Care Finance
. 2011 Feb;
37(2):27-48.
PMID: 21294437
Pharmaceutical firms can apply for the Food and Drug Administration to 'fast track' research and de velopment on new drugs, accelerating clinical trials and expediting regulatory review required prior to...